JPRN-UMIN000021584已完成未知
Effects of sodium-glucose co-transporter 2 inhibitor on metabolic parameters in patients with diabetes mellitus - Effects of SGLT2 inhibitor on metabolic parameters in patients with diabetes mellitus
agoya University0 个研究点目标入组 150 人开始时间: 2016年3月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 25years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
1 期
Effects of sodium glucose co-transporter-2 inhibitor on atrial arrhythmia burden in patient with cardiovascular implantable electronic device: a randomized controlled trialAtrial fibrillation in patients with cardiac implantable electronic deviceTCTR20210315003Faculty of Medicine, Chiang Mai University166
尚未招募
3 期
A clinical trial to study the effect of a drug,dapagliflozin in type 2 diabetic mellitus patient having diabetic macular edemaCTRI/2019/03/017915Postgraduate Institute of Medical Education and Research
尚未招募
4 期
Effects of SGLT2 Inhibitor Therapy on Pancreatic and hepatic fat content in patients of Type 2 Diabetes MellitusCTRI/2019/08/020909ASTRA ZENECA PHARMACEUTICAL INDIA
已完成
不适用
Sodium-glucose cotransporter 2 inhibition reduces body weight but not plasma glucose level in patients with type2 diabetes and mild renal failureJPRN-UMIN000038103Manda Memorial Hospital80
已完成
不适用
Effects of sodium/glucose cotransporter 2 (SGLT2) inhibitors on metabolic parameters in patients with type 2 diabetes: A chart-based analysistype 2 diabetesJPRN-UMIN000020314ational Center for Global Health and Medicine Kohnodai Hospital75